Abstract
We attempt to demonstrate the association between neuroleptic-induced hyperprolactinemia and sexual dysfunction in schizophrenic patients treated with prolactin-elevating antipsychotics. Our findings indicate that sexual function improved with euprolactinemia in patients switched from treatment with prolactin-elevating antipsychotics to olanzapine.
MeSH terms
-
Adult
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Benzodiazepines / adverse effects
-
Benzodiazepines / therapeutic use
-
Ejaculation / drug effects
-
Female
-
Humans
-
Hyperprolactinemia / blood*
-
Hyperprolactinemia / chemically induced*
-
Male
-
Olanzapine
-
Prolactin / blood*
-
Psychotic Disorders / complications
-
Psychotic Disorders / drug therapy
-
Risperidone / adverse effects
-
Risperidone / therapeutic use
-
Sex Characteristics
-
Sexual Dysfunction, Physiological / blood*
-
Sexual Dysfunction, Physiological / chemically induced*
-
Sexual Dysfunctions, Psychological / chemically induced
-
Sexual Dysfunctions, Psychological / psychology
Substances
-
Antipsychotic Agents
-
Benzodiazepines
-
Prolactin
-
Risperidone
-
Olanzapine